FAIRplex
Platform to power AMP data analysis for systems biology research
Platform · Cloud SaaSCompany source
Company profile
About Verily
Verily is a data platform and technology company purpose-built to power AI for precision health. The company is uniquely positioned at the intersection of technology, data science, and healthcare to create tools that accelerate evidence generation, enable more personalized care, and help manage disease at a population level. Verily offers several key solutions: Pre, an AI-native platform for precision health that enables researchers to harmonize, exchange, govern, and analyze biomedical data; Lightpath, which provides personalized care to help members manage their health; Viewpoint, a solution suite to accelerate clinical research; and Sightline, solutions to monitor and mitigate population-level disease. The company recently launched Verily Me, a consumer health app that provides patients with personalized health recommendations from licensed clinicians. Verily serves customers across government agencies, health systems, life sciences companies, and individual researchers. The company has established significant partnerships with organizations including NIH, CDC, NVIDIA, Samsung, UCHealth, and the University of Colorado Anschutz. Verily operates as an independent company backed by Alphabet and other strategic investors, with a mission to make healthcare more predictive, preventive, and precise through advanced AI and data analytics.
Company description Verily official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Verily?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Acute Myeloid Leukemia
- general population health
- infectious disease
- Parkinson's disease
- rare diseases
Who it serves
- Academic/Research institutions
- Employers
- Government agencies
- Health Plans
- Health Systems
- Individual researchers
- Life Sciences/Pharma
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Gmail, Google Workspace, NVIDIA AI stack, Samsung Galaxy Watch 8.
Geographic context
MarketsGlobal (20K+ researchers worldwide) · North America · United States
Company sourceOfficial website
Company milestones
Platform expansion
March 2026: Announced $300M funding round led by Series X Capital; became independent company from Alphabet; launched Verily Me consumer app at SXSW 2026; announced Samsung Galaxy Watch collaboration at HIMSS26. February 2026: Launched free tier of Pre Exchange and Workbench; achieved Awardable status in DoW Tradewinds Marketplace. October 2025: Launched Verily Pre platform, Verily Me app at HLTH USA 2025, and Lifelong Health Study; announced NVIDIA collaboration and UCHealth strategic partnership. December 2025: Secured $9.2M NIH award extension. May 2026: Announced wastewater monitoring for 2026 world soccer games.
Partnerships
Recorded partners
- Alphabet
- CDC
- Foundation for the National Institutes of Health
- Michael J. Fox Foundation
- NIH All of Us Research Program
- NVIDIA
- RefinedScience
- Samsung Electronics America
- Segmed
- Transcripta Bio
- UCHealth
- University of Colorado Anschutz
- Vanderbilt University Medical Center
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Lightpath
Personalized care to help members manage their health
Platform · Cloud SaaSCompany source
Sightline
Solutions to monitor and mitigate population-level disease
Platform · Cloud SaaSCompany source
Verily Me
Personal, private companion to help members manage their health
Software · Cloud SaaSCompany source
Verily Pre
AI-native platform for precision health
Platform · Cloud SaaSCompany source
Verily Pre Exchange
Data ecosystem for discovering and accessing diverse biomedical datasets
Platform · Cloud SaaSCompany source
Verily Pre Workbench
Integrated analysis environment for collaborative biomedical research
Platform · Cloud SaaSCompany source
Verily Refinery
Overcoming the low-resolution data bottleneck with precision data
Platform · Cloud SaaSCompany source
Viewpoint
Solution suite to accelerate clinical research
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Corrigendum to "Fate and transport of viruses, bacteria and antimicrobial resistance associated with wet wipes and microplastics through wastewater treatment to coastal waters" [Water Research (2026) /126281].Water research · Sep 15, 2026
Fate and transport of viruses, bacteria and antimicrobial resistance associated with wet wipes and microplastics through wastewater treatment to coastal waters.Water research · Sep 15, 2026
A national-scale assessment of hospital contributions to chemical loads in wastewater and the implications for wastewater-based epidemiology.Environment international · Aug 23, 2026
Patient-Facing AI System for Symptom Guidance Using Simulated Encounters and Physician Review: Analytical Validation Study.JMIR formative research · Aug 19, 2026
Wastewater surveillance as an early warning system for fungal pathogens.PLoS pathogens · Aug 1, 2026
Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study.Neurology(R) neuroimmunology & neuroinflammation · Jul 1, 2026
Clinical validation
Clinical-trial records
Nutrition for Precision Health, Powered by the All of UsNCT05701657 · Sponsor · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
20,000+ registered researchers
using NIH All of Us Research Program Researcher Workbench powered by Verily Pre
30 million patients
in Segmed real-world longitudinal database accessible through Exchange
150 million de-identified imaging exams
available through Segmed partnership
2026 World Soccer Games
Providing wastewater data and analytics during the 2026 soccer games to monitor for infectious disease threats across North America as part of health security coalition
Public-facing dashboard for local data and public health insights
RefinedScience
Accelerating development of clinically refined Acute Myeloid Leukemia data resource through Pre Exchange
Making high-quality AML data pipeline available to researchers worldwide to drive faster therapeutic breakthroughs
CDC
Multi-year collaboration to support national wastewater monitoring for timely detection and tracking of infectious diseases to inform public health actions
Selected in 2023 for national wastewater monitoring program
NIH All of Us Research Program
Powering the NIH All of Us Research Program's Researcher Workbench through partnership with Vanderbilt University Medical Center, enabling secure access and analysis of precision health dataset
Serves 20,000+ registered researchers globally
UCHealth and University of Colorado Anschutz
Multi-year strategic collaboration for AI-powered research and care transformation to transform how data is used and care is delivered
Strategic partnership announced with investment backing
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Stephen Gillett
CEO
Stephen Gillett
CEO
Bharat Rajagopal
Chief Revenue Officer
Bharat Rajagopal
Chief Revenue Officer
06 · Company updates
Updates from Verily
Recent articles published on Verily's official website.
This achievement builds on Verily’s long-standing work with the federal government, and will streamline procurement for agencies seeking to use Verily Pre
Read on VerilyVerily in ‘25 and beyond: powering AI for precision health
Read on VerilyAdvancing care delivery in a rapidly changing landscape
Read on VerilyWhat population data could do for the individual — early warning signs with proactive monitoring
Read on VerilyPrecision health blog
Read on Verily07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.